Cargando…
Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment
BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension caused by persistent thromboembolism of the pulmonary arteries. In clinical practice, CTEPH patients often show obstructive ventilatory impairment, even in the absence of a smoking history. Recent r...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656012/ https://www.ncbi.nlm.nih.gov/pubmed/34886828 http://dx.doi.org/10.1186/s12890-021-01779-x |
_version_ | 1784612195735175168 |
---|---|
author | Yanagisawa, Asako Naito, Akira Jujo-Sanada, Takayuki Tanabe, Nobuhiro Ishida, Keiichi Matsumiya, Goro Suda, Rika Kasai, Hajime Sekine, Ayumi Sugiura, Toshihiko Shigeta, Ayako Sakao, Seiichiro Tatsumi, Koichiro Suzuki, Takuji |
author_facet | Yanagisawa, Asako Naito, Akira Jujo-Sanada, Takayuki Tanabe, Nobuhiro Ishida, Keiichi Matsumiya, Goro Suda, Rika Kasai, Hajime Sekine, Ayumi Sugiura, Toshihiko Shigeta, Ayako Sakao, Seiichiro Tatsumi, Koichiro Suzuki, Takuji |
author_sort | Yanagisawa, Asako |
collection | PubMed |
description | BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension caused by persistent thromboembolism of the pulmonary arteries. In clinical practice, CTEPH patients often show obstructive ventilatory impairment, even in the absence of a smoking history. Recent reports imply a tendency for CTEPH patients to have a lower FEV(1.0); however, the mechanism underlying obstructive impairment remains unknown. METHODS: We retrospectively analyzed CTEPH patients who underwent a pulmonary function test and respiratory impedance test to evaluate their exertional dyspnea during admission for right heart catheterization from January 2000 to December 2019. We excluded patients with a smoking history to rule out the effect of smoking on obstructive impairment. RESULTS: A total of 135 CTEPH patients were analyzed. The median FEV(1.0)/FVC was 76.0%, %FEV (1.0) had a negative correlation with the mean pulmonary artery pressure and pulmonary vascular resistance and the CT Angiogram (CTA) obstruction score. A multivariate regression analysis revealed that the CTA obstruction score was an independent factor of a lower %FEV(1.0). In the 54 patients who underwent pulmonary endarterectomy, %FEV(1.0) was improved in some cases and was not in some. Mean PAP largely decreased after PEA in the better %FEV(1.0) improved cases, suggesting that vascular involvement in CTEPH could be associated with spirometry obstructive impairment. CONCLUSION: %FEV(1.0) had a significant correlation with the CTA obstruction score. Obstructive impairment might have an etiological relationship with vascular involvement. Further investigations could shed new light on the etiology of CTEPH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-021-01779-x. |
format | Online Article Text |
id | pubmed-8656012 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86560122021-12-10 Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment Yanagisawa, Asako Naito, Akira Jujo-Sanada, Takayuki Tanabe, Nobuhiro Ishida, Keiichi Matsumiya, Goro Suda, Rika Kasai, Hajime Sekine, Ayumi Sugiura, Toshihiko Shigeta, Ayako Sakao, Seiichiro Tatsumi, Koichiro Suzuki, Takuji BMC Pulm Med Research BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension caused by persistent thromboembolism of the pulmonary arteries. In clinical practice, CTEPH patients often show obstructive ventilatory impairment, even in the absence of a smoking history. Recent reports imply a tendency for CTEPH patients to have a lower FEV(1.0); however, the mechanism underlying obstructive impairment remains unknown. METHODS: We retrospectively analyzed CTEPH patients who underwent a pulmonary function test and respiratory impedance test to evaluate their exertional dyspnea during admission for right heart catheterization from January 2000 to December 2019. We excluded patients with a smoking history to rule out the effect of smoking on obstructive impairment. RESULTS: A total of 135 CTEPH patients were analyzed. The median FEV(1.0)/FVC was 76.0%, %FEV (1.0) had a negative correlation with the mean pulmonary artery pressure and pulmonary vascular resistance and the CT Angiogram (CTA) obstruction score. A multivariate regression analysis revealed that the CTA obstruction score was an independent factor of a lower %FEV(1.0). In the 54 patients who underwent pulmonary endarterectomy, %FEV(1.0) was improved in some cases and was not in some. Mean PAP largely decreased after PEA in the better %FEV(1.0) improved cases, suggesting that vascular involvement in CTEPH could be associated with spirometry obstructive impairment. CONCLUSION: %FEV(1.0) had a significant correlation with the CTA obstruction score. Obstructive impairment might have an etiological relationship with vascular involvement. Further investigations could shed new light on the etiology of CTEPH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-021-01779-x. BioMed Central 2021-12-09 /pmc/articles/PMC8656012/ /pubmed/34886828 http://dx.doi.org/10.1186/s12890-021-01779-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yanagisawa, Asako Naito, Akira Jujo-Sanada, Takayuki Tanabe, Nobuhiro Ishida, Keiichi Matsumiya, Goro Suda, Rika Kasai, Hajime Sekine, Ayumi Sugiura, Toshihiko Shigeta, Ayako Sakao, Seiichiro Tatsumi, Koichiro Suzuki, Takuji Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment |
title | Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment |
title_full | Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment |
title_fullStr | Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment |
title_full_unstemmed | Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment |
title_short | Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment |
title_sort | vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656012/ https://www.ncbi.nlm.nih.gov/pubmed/34886828 http://dx.doi.org/10.1186/s12890-021-01779-x |
work_keys_str_mv | AT yanagisawaasako vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT naitoakira vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT jujosanadatakayuki vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT tanabenobuhiro vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT ishidakeiichi vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT matsumiyagoro vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT sudarika vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT kasaihajime vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT sekineayumi vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT sugiuratoshihiko vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT shigetaayako vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT sakaoseiichiro vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT tatsumikoichiro vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment AT suzukitakuji vascularinvolvementinchronicthromboembolicpulmonaryhypertensionisassociatedwithspirometryobstructiveimpairment |